Investing in hardware and the data layer
Over the past couple of months, we have written about a range of themes that have been interesting to us lately. Through public brainstorming, we have met some inspiring entrepreneurs, been introduced to some cool companies and received some great feedback. All in all, we have been enjoying the process of refining our thesis in […]
Three Questions with Bala Subramaniam: Marketplaces
I recently caught up with my good friend Bala Subramaniam, who is the Head of Fulfillment at Instacart. You may remember Bala’s talk on supply-demand equilibrium at our data-driven marketplace meetup back in May 2017. Bala is a seasoned product, business, and technology leader. Before Instacart, he was at LinkedIn and Microsoft. I always learn a ton […]
Investing in digital health and wellness apps
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and therapeutics. Our previous posts on this topic haven’t included digital health and wellness apps, but these consumer-facing products certainly play an important role in transforming healthcare and democratizing its access. The consumerization of healthcare through apps continues to pick up […]
Investing in biotech and therapeutics
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have come from startups in biotech, specifically companies developing therapeutics. From non-hormonal contraceptives that work for men and women to muscle-promoting gene therapy, the potential impact of these new drugs is both immeasurable and inspiring. So, it comes as no surprise […]
Q4 2018: Portfolio News and Activities
We are well into 2019. And yes, this is the time of year when people are thinking about resolutions and looking ahead. And while we are very excited about the new year and new fund, we also want to spend a few minutes to reflect on last quarter. Q4 was an important quarter for our […]